347 related articles for article (PubMed ID: 3931467)
1. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.
Falko JM; Osei K
Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467
[TBL] [Abstract][Full Text] [Related]
2. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.
Osei K; O'Dorisio TM; Falko JM
Am J Med; 1984 Dec; 77(6):1002-9. PubMed ID: 6439036
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
DeFronzo RA; Goodman AM
N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
[TBL] [Abstract][Full Text] [Related]
4. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
Dailey GE; Mohideen P; Fiedorek FT
Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
[TBL] [Abstract][Full Text] [Related]
5. Treatment of type I diabetes with a combination of glyburide and insulin.
Gums JG; Curry RW; Montes de Oca G; Skluth HA; Reynolds LR
Ann Pharmacother; 1992 Jun; 26(6):757-62. PubMed ID: 1611155
[TBL] [Abstract][Full Text] [Related]
6. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent.
Osei K; Falko JM
Am J Med Sci; 1985 Apr; 289(4):148-53. PubMed ID: 3920907
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide versus glyburide: a one-year comparison trial.
Marbury T; Huang WC; Strange P; Lebovitz H
Diabetes Res Clin Pract; 1999 Mar; 43(3):155-66. PubMed ID: 10369424
[TBL] [Abstract][Full Text] [Related]
8. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.
Nathan DM; Roussell A; Godine JE
Ann Intern Med; 1988 Mar; 108(3):334-40. PubMed ID: 3124685
[TBL] [Abstract][Full Text] [Related]
9. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
Roberts VL; Stewart J; Issa M; Lake B; Melis R
Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined insulin-sulfonylurea therapy in type II patients.
Lewitt MS; Yu VK; Rennie GC; Carter JN; Marel GM; Yue DK; Hooper MJ
Diabetes Care; 1989 Jun; 12(6):379-83. PubMed ID: 2499443
[TBL] [Abstract][Full Text] [Related]
11. Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study.
Garber AJ; Bruce S; Fiedorek FT
Clin Ther; 2002 Sep; 24(9):1401-13. PubMed ID: 12380632
[TBL] [Abstract][Full Text] [Related]
12. A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.
Erle G; Lovise S; Stocchiero C; Lora L; Coppini A; Marchetti P; Merante D
Acta Diabetol; 1999 Jun; 36(1-2):61-5. PubMed ID: 10436254
[TBL] [Abstract][Full Text] [Related]
13. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
[TBL] [Abstract][Full Text] [Related]
14. Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.
Hollander PA; Schwartz SL; Gatlin MR; Haas SJ; Zheng H; Foley JE; Dunning BE
Diabetes Care; 2001 Jun; 24(6):983-8. PubMed ID: 11375357
[TBL] [Abstract][Full Text] [Related]
15. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.
Groop L; Harno K; Nikkilä EA; Pelkonen R; Tolppanen EM
Acta Med Scand; 1985; 217(1):33-9. PubMed ID: 3919531
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.
Raz I; Stranks S; Filipczak R; Joshi P; Lertoft B; Rastam J; Chow CC; Shaban J
Clin Ther; 2005 Sep; 27(9):1432-43. PubMed ID: 16291416
[TBL] [Abstract][Full Text] [Related]
17. Insulin-glyburide combination therapy for non-insulin-dependent diabetes mellitus: a long-term double-blind, placebo-controlled trial.
Casner PR
Clin Pharmacol Ther; 1988 Nov; 44(5):594-603. PubMed ID: 3141099
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.
Riddle M; Hart J; Bingham P; Garrison C; McDaniel P
Am J Med Sci; 1992 Mar; 303(3):151-6. PubMed ID: 1595776
[TBL] [Abstract][Full Text] [Related]
19. Effects of combination therapy with glyburide and insulin on serum lipid levels in NIDDM patients with secondary sulfonylurea failure.
Karlander SG; Gutniak MK; Efendic S
Diabetes Care; 1991 Nov; 14(11):963-7. PubMed ID: 1797509
[TBL] [Abstract][Full Text] [Related]
20. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]